Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: Egyesült Államok3. fázis

Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease

A legfontosabb adatok

Hol
Albuquerque, Amarillo, Asheville, Atlanta, Baton Rouge, Burbank, Canton, Champaign, Chattanooga, Cincinnati, Dallas, Denton, Doral, El Paso, Farmington Hills, Fayetteville, Fort Myers, Greenville, Hialeah, Hollywood, Houston, Huntington Beach, Kansas City, La Jolla, Las Vegas, Layton, Lenexa, McKinney, Memphis, Miami, Midlothian, Morehead City, Norman, North Charleston, Oak Brook, Oakland, Orchard Park, Palm Beach Gardens, Philadelphia, Raleigh, San Antonio, San Diego, Seattle, Shavano Park, South Gate, Springfield, St Louis, Statesville, Tampa, Tucson, Walnut Creek, Washington D.C., Weslaco és Wilmington (Egyesült Államok)Mind a 57 helyszín megnézése
Fázis
3. fázis

Neked szólhat?

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 70 év között vagy?

Forrás: NCT07661056: ki vehet részt

Helyszínek itt: Egyesült Államok

  • Albuquerque, New MexicoHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Amarillo, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Asheville, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Atlanta, GeorgiaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Baton Rouge, LouisianaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Burbank, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Canton, OhioHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Champaign, IllinoisHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Chattanooga, TennesseeHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Cincinnati, OhioHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Dallas, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Dallas, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Denton, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Doral, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • El Paso, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Farmington Hills, MichiganHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Fayetteville, GeorgiaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Fort Myers, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Greenville, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Hialeah, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Hollywood, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Houston, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Huntington Beach, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Kansas City, MissouriHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • La Jolla, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Las Vegas, NevadaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Layton, UtahHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Lenexa, KansasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • McKinney, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Memphis, TennesseeHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Miami, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Midlothian, VirginiaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Morehead City, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Morehead City, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Norman, OklahomaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • North Charleston, South CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Oak Brook, IllinoisHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Oakland, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Orchard Park, New YorkHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Palm Beach Gardens, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Philadelphia, PennsylvaniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Raleigh, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • San Antonio, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • San Diego, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Seattle, WashingtonHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Shavano Park, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • South Gate, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Springfield, IllinoisHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • St Louis, MissouriHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Statesville, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Tampa, FloridaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Tucson, ArizonaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Walnut Creek, CaliforniaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Washington D.C., District of ColumbiaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Weslaco, TexasHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres
  • Wilmington, North CarolinaHospital not named in the registryContact: Chief Medical OfficerRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Biohaven Therapeutics Ltd.
Azonosító
NCT07661056EU 2026-526455-53-00
A regiszteradat frissítve
2026. november 12.
Eredeti leírás
The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroidA teljes eredeti leírásKevesebb

A Phase 3, Double-blind, Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Efficacy, Safety and Tolerability of BHV-1300 in the Treatment of Adults With Graves' Disease

The purpose of this study is to evaluate the efficacy and safety of BHV-1300 in adult participants with Graves' disease who are actively hyperthyroid

Bevonási feltételek: Participants must have serologically confirmed Graves' disease as documented by presence of elevated autoantibodies; Participants must have active hyperthyroidism due to Graves' disease.

Kizáró feltételek: History of treatment with radioactive iodine or thyroid surgery; Have received levothyroxine, desiccated thyroid extract, or T3 at any dose within six weeks of the Baseline/Day 1 Visit; Are expected to require urgent or emergent thyroid surgery or ablation within six weeks of Baseline/Day 1 or throughout the study; History of hyperthyroidism not caused by Graves' Disease (e.g., toxic adenoma or toxic multinodular goiter); Thyroid storm, i.e. severe thyrotoxicosis with evidence of systemic decompensation (e.g., Burch-Wartkofsky Point Scale of ≥ 45 or Japanese Thyroid Association category 1 or 2, with accompanying manifestations including hyperpyrexia, tachycardia, arrhythmias, congestive heart failure, agitation, delirium, psychosis, stupor, and coma, as well as nausea, vomiting, diarrhea, or hepatic failure) within 6 weeks of Screening; Have autoimmune disease other than Graves' disease requiring treatment; Have moderate to severe thyroid eye disease (TED) or are expected to require immediate surgical intervention and/or are planning corrective surgery/irradiation or medical therapy for TED during study participation.

ClinicalTrials.gov NCT07661056 · EU CTIS 2026-526455-53-00